• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Neuropsychiatric and Cognitive Changes in Parkinson's Disease and Related Movement Disorders: Diagnosis and Management

Neuropsychiatric and Cognitive Changes in Parkinson's Disease and Related Movement Disorders: Diagnosis and Management

9781107039223
617,34 zł
555,60 zł Zniżka 61,74 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 555,60 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD lub Pocztę Polską. Kliknij po więcej szczegółów

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni. Kliknij po więcej szczegółów

Opis
Psychiatric and cognitive changes are common in patients with Parkinsons disease and have key clinical consequences but, despite this, these symptoms are often under-diagnosed and under-treated, leading to increased morbidity and costs. With chapters focused on the major neuropsychiatric features, Neuropsychiatric and Cognitive Changes in Parkinsons Disease and Related Movement Disorders rectifies this deficit. Written by experts in the field, with a consistent focus on relevant clinical knowledge, it provides a comprehensive overview including all the major behavioral changes associated with movement disorders. The book provides broad, in-depth, accurate and up-to-date scientific information as well as crucial understanding and practical tools to help patients. The book is essential reading for clinicians working in neurology, psychiatry and geriatric medicine.
Szczegóły produktu
66604
9781107039223
9781107039223

Opis

Rok wydania
2013
Numer wydania
1
Oprawa
twarda
Liczba stron
307
Wymiary (mm)
193.00 x 252.00
Waga (g)
900
  • Preface; Part I. General Aspects:: 1. Overview of Parkinsons disease:: epidemiology, diagnosis, course, medical and surgical management Sheila S. Rane and Christopher G. Goetz; 2. Parkinsons disease:: pathology, anatomy, and behavior James B. Leverenz and Daniel J. Burdick; 3. Genetics and behavior and cognition in Parkinsons disease Caroline H. Williams-Gray and Roger A. Barker; 4. The boundaries of Parkinsons disease dementia and dementia with Lewy bodies Elisabet Londos; Part II. Diagnosis and Biomarkers:: 5. Cognitive assessment in Parkinsons disease Jaime Kulisevsky, Saül Martinez-Horta and Javier Pagonabarraga; 6. Clinical assessment:: mood and motivation Albert F. G. Leentjens; 7. Imaging and behavior in Parkinsons disease:: structural imaging Mona K. Beyer, Turi O. Dalaker and Liana G. Apostolova; 8. Imaging and behavior in Parkinsons disease:: functional imaging Agneta Nordberg; 9. Diagnosis and biomarkers:: CSF Brit Mollenhauer and Henrik Zetterberg; Part III. Specific Neuropsychiatric Disorders:: 10. Depression Per Svenningsson and Dag Aarsland; 11. Anxiety Laura Marsh and Jessica Calleo; 12. Apathy Kathy Dujardin; 13. Impulse control disorder Daniel Weintraub and Irena Rektorova; 14. Hallucinations and psychosis Oscar Bernal-Pacheco and Hubert H. Fernandez; 15. Early cognitive impairment Alexander I. Tröster and Dag Aarsland; 16. Parkinsons disease dementia:: features and management Basar Bilgic, Hasmet A. Hana?asi and Murat Emre; 17. Sleep disturbances Pouya Movahed, Kristina R?kenes Karlsen and K. Ray Chaudhuri; Part IV. Management:: 18. Parkinsons disease:: drug treatment and behavior Jaime Kulisevsky, Javier Pagonabarraga and Carolina Villa-Bonomo; 19. Surgical treatments and behavior Jens Volkmann and Christine Daniels; 20. Clinical trials for psychotropic agents in Parkinsons diesase using psychosis as a model Ryan R. Walsh and Jeffrey Cummings; Part V. Other Issues:: 21. Clinical implications of neuropsychiatric symptoms in Parkinsons disease Angelo Antonini and Pablo Martinez-Martin; 22. Neuropsychiatric and cognitive disorders in other Parkinsonian disorders Adam Gerstenecker, Benjamin T. Mast and Irene Litvan; 23. Neuropsychiatric aspects of the on-off phenomenon Irene Rektorova and Marek Balaz; 24. Treatment of neuropsychiatric disturbances in Parkinsons disease:: future prospects and strategies Jeffery Cummings and Dag Aarsland; Index.
Komentarze (0)